Medtech executive consulting and steady leadership for great companies facing turnaround, turbulence and change.
I work with turnaround firms, boards, and investors to rebuild trust, refocus strategy, and restore momentum in Medtech, Diagnostic, and Life Science companies. I bring clinical and scientific fluency to medtech executive consulting during high-stakes situations, collaborating closely with legal, finance, and turnaround specialists to align stakeholders and provide steady, credible leadership.
Trusted By…
I collaborate with leadership teams across private and publicly traded Medtech companies, as well as venture firms, private equity investors, academic institutions, and federal agencies. Whether building, rebuilding, or repositioning, my work is grounded in trust, discretion, and a shared urgency to deliver results.












About ArgoPond
Our Mission
ArgoPond provides hands-on strategic and operational support to medtech companies navigating moments of growth, turbulence, or transition. We focus on driving clarity, action, and alignment when stakes are high and time is short.
Who We Support
Founded and led by John Younger, MD, ArgoPond engages with medtech companies across the full lifecycle—from the first capital raised to life as a publicly traded company. We work directly with executive teams, boards, and investors to solve challenges in strategy, execution, and recovery.
Our clients include early-stage innovators, growth-phase ventures, public companies, and institutional investors seeking experienced leadership and trusted guidance.
What We Offer
While there’s no end to how challenges might present themselves, our engagements most often focus on:
- Early-stage commercialization strategy and preparation
- Stabilization, restructuring, and turnaround
- Fractional and interim executive leadership (e.g., CEO or other C-suite roles, Head of Medical Affairs)
- Board and investor support and alignment during times of uncertainty or reduced confidence
What Clients Say

About John Younger, MD
John brings over two decades of experience as a founder, operator, investor, and physician-scientist. He launched venture-backed start-ups, managed early-stage investment funds, and was invited to step in as CEO of a commercial-stage medtech company during its recent restructuring.
Dr. Younger's physician-scientist career leading NIH-funded basic, translational, and clinical research programs at the University of Michigan. He was the first emergency physician to serve on any NIH advisory council, and the first entrepreneur appointed to the National Advisory Council for the National Institute of General Medical Sciences (NIGMS).
John has also provided expert testimony before the U.S. House of Representatives Committee on Small Business, offering recommendations on how federal policy might better support early-stage life science companies beyond the traditional SBIR grant mechanism.
Whether the goal is to build, fix, or pivot, ArgoPond engages with clarity, urgency, and integrity—always with the aim of driving durable value for patients, companies, and shareholders alike.